{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:36:28Z","timestamp":1794353788257,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,2,18]]},"DOI":"10.1038\/s41388-025-03669-6","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:25:19Z","timestamp":1767781519000},"page":"650-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An H4K12la\/CEBPB-AKR1C2 signaling axis modulates the mTOR pathway to regulate cisplatin resistance in lung cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Wenjing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-4696","authenticated-orcid":false,"given":"Jinhan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"3669_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"3669_CR2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"3669_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","volume":"44","author":"DA Fennell","year":"2016","unstructured":"Fennell DA, Summers Y, Cadranel J, Benepal T, Christoph DC, Lal R, et al. Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Treat Rev. 2016;44:42\u201350.","journal-title":"Cancer Treat Rev"},{"key":"3669_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10555-007-9045-3","volume":"26","author":"MT Kuo","year":"2007","unstructured":"Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev. 2007;26:71\u201383.","journal-title":"Cancer Metastasis Rev"},{"key":"3669_CR5","volume":"10","author":"ZH Li","year":"2012","unstructured":"Li ZH, Qiu MZ, Zeng ZL, Luo HY, Wu WJ, Wang F, et al. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). J Transl Med. 2012;10:21.","journal-title":"J Transl Med"},{"key":"3669_CR6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ptr.6584","volume":"34","author":"XZ Liao","year":"2020","unstructured":"Liao XZ, Gao Y, Sun LL, Liu JH, Chen HR, Yu L, et al. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway. Phytother Res. 2020;34:1142\u201353.","journal-title":"Phytother Res"},{"key":"3669_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lungcan.2011.06.011","volume":"75","author":"HH Chen","year":"2012","unstructured":"Chen HH, Yan JJ, Chen WC, Kuo MT, Lai YH, Lai WW, et al. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy. Lung Cancer. 2012;75:228\u201334.","journal-title":"Lung Cancer"},{"key":"3669_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.428","volume":"5","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, et al. Systems biology of cisplatin resistance: past, present and future. Cell Death Dis. 2014;5:e1257.","journal-title":"Cell Death Dis"},{"key":"3669_CR9","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/1078-0432.CCR-18-3094","volume":"25","author":"JR Heyza","year":"2019","unstructured":"Heyza JR, Lei W, Watza D, Zhang H, Chen W, Back JB, et al. Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clin Cancer Res. 2019;25:2523\u201336.","journal-title":"Clin Cancer Res"},{"key":"3669_CR10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.lungcan.2013.08.018","volume":"82","author":"F Mazzoni","year":"2013","unstructured":"Mazzoni F, Cecere FL, Meoni G, Giuliani C, Boni L, Camerini A, et al. Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer. Lung Cancer. 2013;82:288\u201393.","journal-title":"Lung Cancer"},{"key":"3669_CR11","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-4-18","volume":"4","author":"DA Weaver","year":"2005","unstructured":"Weaver DA, Crawford EL, Warner KA, Elkhairi F, Khuder SA, Willey JC. ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer. 2005;4:18.","journal-title":"Mol Cancer"},{"key":"3669_CR12","first-page":"2887","volume":"9","author":"T Ren","year":"2015","unstructured":"Ren T, Shan J, Li M, Qing Y, Qian C, Wang G, et al. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer. Drug Des Devel Ther. 2015;9:2887\u2013910.","journal-title":"Drug Des Devel Ther"},{"key":"3669_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fphar.2018.00092","volume":"9","author":"CY Sun","year":"2018","unstructured":"Sun CY, Zhu Y, Li XF, Wang XQ, Tang LP, Su ZQ, et al. Scutellarin increases Cisplatin-induced apoptosis and autophagy to overcome cisplatin resistance in non-small cell lung cancer via ERK\/p53 and c-met\/AKT signaling pathways. Front Pharmacol. 2018;9:92.","journal-title":"Front Pharmacol"},{"key":"3669_CR14","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","volume":"70","author":"JP Sullivan","year":"2010","unstructured":"Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010;70:9937\u201348.","journal-title":"Cancer Res"},{"key":"3669_CR15","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Liu X, Ren Y, Zhang J, Chen J, Zhou W, et al. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1\/HDAC activity. Cell Death Dis. 2017;8:e2746.","journal-title":"Cell Death Dis"},{"key":"3669_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","volume":"128","author":"AD Goldberg","year":"2007","unstructured":"Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128:635\u20138.","journal-title":"Cell"},{"key":"3669_CR17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487\u2013500.","journal-title":"Nat Rev Genet"},{"key":"3669_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693\u2013705.","journal-title":"Cell"},{"key":"3669_CR19","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","volume":"10","author":"T Huang","year":"2020","unstructured":"Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10:8721\u201343.","journal-title":"Theranostics"},{"key":"3669_CR20","volume":"19","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao M, Cui L, Ren Y, Zhang J, Chen J, et al. Characterization of a novel HDAC\/RXR\/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer. Mol Cancer. 2020;19:134.","journal-title":"Mol Cancer"},{"key":"3669_CR21","volume":"21","author":"W Wang","year":"2022","unstructured":"Wang W, Wang J, Liu S, Ren Y, Wang J, Liu S, et al. An EHMT2\/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer. Mol Cancer. 2022;21:106.","journal-title":"Mol Cancer"},{"key":"3669_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3669_CR23","doi-asserted-by":"crossref","first-page":"30628","DOI":"10.1073\/pnas.2009778117","volume":"117","author":"RA Irizarry-Caro","year":"2020","unstructured":"Irizarry-Caro RA, McDaniel MM, Overcast GR, Jain VG, Troutman TD, Pasare C. TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation. Proc Natl Acad Sci USA. 2020;117:30628\u201338.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3669_CR24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s42255-020-0267-9","volume":"2","author":"L Li","year":"2020","unstructured":"Li L, Chen K, Wang T, Wu Y, Xing G, Chen M, et al. Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade. Nat Metab. 2020;2:882\u201392.","journal-title":"Nat Metab"},{"key":"3669_CR25","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.7150\/ijbs.73398","volume":"18","author":"J Yang","year":"2022","unstructured":"Yang J, Luo L, Zhao C, Li X, Wang Z, Zeng Z, et al. A positive feedback loop between inactive vhl-triggered histone lactylation and PDGFR\u03b2 signaling drives clear cell renal cell carcinoma progression. Int J Biol Sci. 2022;18:3470\u201383.","journal-title":"Int J Biol Sci"},{"key":"3669_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M, Chandel NS. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 2020;32:341\u201352.","journal-title":"Cell Metab"},{"key":"3669_CR27","doi-asserted-by":"crossref","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","volume":"18","author":"H Lu","year":"2024","unstructured":"Lu H, Tong W, Jiang M, Liu H, Meng C, Wang K, et al. Mitochondria-targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer. ACS Nano. 2024;18:21156\u201370.","journal-title":"ACS Nano"},{"key":"3669_CR28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/cdd.2016.39","volume":"23","author":"DS Matassa","year":"2016","unstructured":"Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, et al. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ. 2016;23:1542\u201354.","journal-title":"Cell Death Differ"},{"key":"3669_CR29","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03447-y","volume":"20","author":"S Sriramkumar","year":"2022","unstructured":"Sriramkumar S, Sood R, Huntington TD, Ghobashi AH, Vuong TT, Metcalfe TX, et al. Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer. J Transl Med. 2022;20:246.","journal-title":"J Transl Med"},{"key":"3669_CR30","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1093\/eurheartj\/ehae379","volume":"45","author":"X Li","year":"2024","unstructured":"Li X, Chen M, Chen X, He X, Li X, Wei H, et al. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation. Eur Heart J. 2024;45:4219\u201335.","journal-title":"Eur Heart J"},{"key":"3669_CR31","volume":"488","author":"H Wang","year":"2025","unstructured":"Wang H, Xia H, Bai J, Wang Z, Wang Y, Lin J, et al. H4K12 lactylation-regulated NLRP3 is involved in cigarette smoke-accelerated Alzheimer-like pathology through mTOR-regulated autophagy and activation of microglia. J Hazard Mater. 2025;488:137310.","journal-title":"J Hazard Mater"},{"key":"3669_CR32","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang X. Virus-induced histone lactylation promotes virus infection in crustacean. Adv Sci. 2024;11:e2401017.","journal-title":"Adv Sci"},{"key":"3669_CR33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, et al. Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res. 2022;131:893\u2013908.","journal-title":"Circ Res"},{"key":"3669_CR34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109820","volume":"37","author":"H Hagihara","year":"2021","unstructured":"Hagihara H, Shoji H, Otabi H, Toyoda A, Katoh K, Namihira M, et al. Protein lactylation induced by neural excitation. Cell Rep. 2021;37:109820.","journal-title":"Cell Rep"},{"key":"3669_CR35","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:85.","journal-title":"Genome Biol"},{"key":"3669_CR36","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1093\/nar\/gkae501","volume":"52","author":"E Di Giorgio","year":"2024","unstructured":"Di Giorgio E, Dalla E, Tolotto V, D\u2019Este F, Paluvai H, Ranzino L, et al. HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1\/HDAC2 to control H2BK120 acetylation and homology-directed repair. Nucleic Acids Res. 2024;52:8218\u201340.","journal-title":"Nucleic Acids Res"},{"key":"3669_CR37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8:eabi6696.","journal-title":"Sci Adv"},{"key":"3669_CR38","doi-asserted-by":"crossref","unstructured":"Huang H, Zhang D, Weng Y, Delaney K, Tang Z, Yan C, et al. The regulatory enzymes and protein substrates for the lysine \u03b2-hydroxybutyrylation pathway. Sci Adv. 2021;7:eabe2771.","DOI":"10.1126\/sciadv.abe2771"},{"key":"3669_CR39","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.molcel.2023.05.022","volume":"83","author":"N Liu","year":"2023","unstructured":"Liu N, Konuma T, Sharma R, Wang D, Zhao N, Cao L, et al. Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin. Mol Cell. 2023;83:2206\u201321.e11.","journal-title":"Mol Cell"},{"key":"3669_CR40","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2008.19.3235","volume":"27","author":"JR Eckardt","year":"2009","unstructured":"Eckardt JR, Bentsion DL, Lipatov ON, Polyakov IS, Mackintosh FR, Karlin DA, et al. Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer. J Clin Oncol. 2009;27:2046\u201351.","journal-title":"J Clin Oncol"},{"key":"3669_CR41","volume":"203","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhang LX, Jiang T, Long J, Ma ZY, Lu AP, et al. The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction. Eur J Med Chem. 2020;203:112570.","journal-title":"Eur J Med Chem"},{"key":"3669_CR42","doi-asserted-by":"crossref","first-page":"31440","DOI":"10.1016\/S0021-9258(19)84056-5","volume":"281","author":"AM Fribley","year":"2006","unstructured":"Fribley AM, Evenchik B, Zeng Q, Park BK, Guan JY, Zhang H, et al. Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa. J Biol Chem. 2006;281:31440\u20137.","journal-title":"J Biol Chem"},{"key":"3669_CR43","volume":"30","author":"L Ye","year":"2024","unstructured":"Ye L, Gu L, Wang Y, Xing H, Li P, Guo X, et al. Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data. CNS Neurosci Ther. 2024;30:e14649.","journal-title":"CNS Neurosci Ther"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03669-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:02:59Z","timestamp":1769554979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03669-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,2,18]]}},"alternative-id":["3669"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03669-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research presented here has been performed in accordance with the Declaration of Helsinki and has been approved by the ethics committee of Sichuan University and West China Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}